4CPS-316 Multiple sclerosis outpatient pharmaceutical care by an implanted telepharmacy tool during SARS-CoV-2 pandemic
CG Perez, AG Sacristan, ER Sanchez, JAP Pedrosa… - 2021 - ejhp.bmj.com
Background and importance The SARS-CoV-2 pandemic has highlighted the need to avoid
exposure of patients to places with a high probability of transmission, such as hospitals …
exposure of patients to places with a high probability of transmission, such as hospitals …
3PC-035 Patch tests with hazardous drugs: is it possible to ensure safety during production?
MFV Crespo, VP Garcia, PP Vara, NSO Martín… - 2024 - ejhp.bmj.com
Background and Importance Epicutaneous Patch Tests (EPTs) are the first type of skin tests
performed by Allergology Department to diagnose Type IV hypersensitivity allergic reactions …
performed by Allergology Department to diagnose Type IV hypersensitivity allergic reactions …
4CPS-128 Adequacy of nivolumab and pembrolizumab in non-small-cell lung cancer
ER Sánchez, C González-Pérez, MPP Ramos… - 2019 - ejhp.bmj.com
Background Between 2016 and 2017 the National Agency of Medicines and Medical
Devices regulated the use of nivolumab and pembrolizumab for the treatment of non-small …
Devices regulated the use of nivolumab and pembrolizumab for the treatment of non-small …
2SPD-036 Storage and dispensing of solid oral dosage forms from multiple unit containers
MLR Blazquez, ER Sánchez, JMM Sesmero… - 2019 - ejhp.bmj.com
Background Solid oral dosage forms packed in multiple unit containers (SODF-MUC) are
exposed, when the package is opened, to the hospital and patients' home conditions (light …
exposed, when the package is opened, to the hospital and patients' home conditions (light …
5PSQ-053 Adaptation of prophylaxis against varicella–zoster virus in patients with multiple myeloma
IL Espejo, CT Martinez, ER Sanchez, GH Llorente… - 2019 - ejhp.bmj.com
Background Patients with a diagnosis of multiple myeloma (MM) have compromised innate
and adaptive immunity, both humoral and cellular. The treatment of this pathology can …
and adaptive immunity, both humoral and cellular. The treatment of this pathology can …
4CPS-214 Implementation of a clinical pharmacist in an internal medicine service of a tertiary referral hospital
AP Morales, AN Sanchez, MM Bailon, AS Pérez… - 2018 - ejhp.bmj.com
Background The presence of a clinical pharmacist in the medical services has been shown
in numerous previous publications as a great additional factor in the quality and safety of …
in numerous previous publications as a great additional factor in the quality and safety of …
[CITATION][C] STORAGE AND DISPENSING OF SOLID ORAL DOSAGE FORMS FROM MULTIPLE UNIT CONTAINERS
MLR BLÁZQUEZ, ER SÁNCHEZ, JMM SESMERO…